Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1608140-48-2 | endo-BCN-PEG8-NHS ester | AA019ECK | MFCD31692212
2183473-49-4 | BDP TR hydrazide | AA019EGH | MFCD31580093
1097164-22-1 | 1-(2,5-Dimethoxyphenyl)-2-(4-fluorophenyl)ethanone | AA019EJP | MFCD13660606
1064677-18-4 | (3-Bromo-5-chloropyridin-4-yl)methanol | AA019EMV | MFCD16606989
1496165-49-1 | 3-Methyl-2-(4-methylphenyl)morpholine hydrochloride | AA019EQ7 | MFCD28166374
705271-61-0 | 4-Methyl-6-nitro-2-(pyrrolidin-1-yl)quinoline | AA019ETE | MFCD03828546
1282306-68-6 | N-Benzyl-4-bromo-3-fluorobenzamide | AA019EWU | MFCD16509482
36131-47-2 | Ethyl 5-formyl-4-nitro-1H-pyrrole-2-carboxylate | AA019EZP | MFCD25962723
54029-20-8 | Methyl (5-(phenylsulfonyl)-1H-benzo[d]imidazol-2-yl)carbamate | AA019FSY | MFCD00797921
328028-53-1 | 4-(2-Chloro-5-nitro-benzenesulfonylamino)-benzoic acid | AA019GFP | MFCD00682824